Telsey Advisory Group reaffirmed their outperform rating on shares of Levi Strauss & Co. (NYSE:LEVI – Free Report) in a research note issued to investors on Wednesday morning,Benzinga reports. Telsey Advisory Group currently has a $26.00 price target on the blue-jean maker’s stock.
A number of other brokerages have also weighed in on LEVI. Stifel Nicolaus dropped their price objective on Levi Strauss & Co. from $28.00 to $25.00 and set a “buy” rating on the stock in a report on Thursday, October 3rd. Morgan Stanley cut their price target on shares of Levi Strauss & Co. from $19.00 to $18.00 and set an “equal weight” rating for the company in a report on Tuesday. Citigroup reduced their price objective on shares of Levi Strauss & Co. from $21.00 to $19.00 and set a “neutral” rating for the company in a research note on Friday, January 17th. TD Cowen lowered their target price on shares of Levi Strauss & Co. from $25.00 to $23.00 and set a “buy” rating on the stock in a research report on Thursday, October 3rd. Finally, Barclays began coverage on shares of Levi Strauss & Co. in a research report on Wednesday, January 8th. They set an “overweight” rating and a $24.00 price target for the company. Five investment analysts have rated the stock with a hold rating and six have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, Levi Strauss & Co. currently has a consensus rating of “Moderate Buy” and a consensus target price of $22.30.
Get Our Latest Stock Report on LEVI
Levi Strauss & Co. Price Performance
Insider Activity at Levi Strauss & Co.
In related news, Director David A. Friedman sold 4,166 shares of the business’s stock in a transaction dated Monday, January 6th. The shares were sold at an average price of $18.00, for a total value of $74,988.00. Following the completion of the transaction, the director now owns 104,178 shares of the company’s stock, valued at approximately $1,875,204. The trade was a 3.85 % decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. 3.14% of the stock is owned by corporate insiders.
Institutional Investors Weigh In On Levi Strauss & Co.
Hedge funds have recently modified their holdings of the company. Asset Management One Co. Ltd. purchased a new position in shares of Levi Strauss & Co. during the third quarter valued at approximately $27,000. Quarry LP acquired a new position in Levi Strauss & Co. in the 2nd quarter valued at $56,000. Matrix Trust Co lifted its stake in shares of Levi Strauss & Co. by 678.9% during the 4th quarter. Matrix Trust Co now owns 5,507 shares of the blue-jean maker’s stock worth $95,000 after purchasing an additional 4,800 shares during the period. Point72 Asia Singapore Pte. Ltd. boosted its holdings in shares of Levi Strauss & Co. by 2,904.1% during the third quarter. Point72 Asia Singapore Pte. Ltd. now owns 5,137 shares of the blue-jean maker’s stock worth $112,000 after purchasing an additional 4,966 shares during the last quarter. Finally, SG Americas Securities LLC grew its position in shares of Levi Strauss & Co. by 32.9% in the fourth quarter. SG Americas Securities LLC now owns 12,103 shares of the blue-jean maker’s stock valued at $209,000 after purchasing an additional 2,998 shares during the period. 69.14% of the stock is owned by institutional investors and hedge funds.
Levi Strauss & Co. Company Profile
Levi Strauss & Co engages in the design, marketing, and sale of apparel products. The company offers jeans, casual and dress pants, tops, shorts, skirts, jackets, footwear, and related accessories. It operates through the following geographical segments: Americas, Europe, and Asia. The company was founded by Levi Strauss in 1853 and is headquartered in San Francisco, CA.
Featured Articles
- Five stocks we like better than Levi Strauss & Co.
- Are Penny Stocks a Good Fit for Your Portfolio?
- Oracle Announces Game-Changing News for the AI Industry
- Where Do I Find 52-Week Highs and Lows?
- Netflix Adds 19 Million Subscribers, Growth Is Far From Over
- Health Care Stocks Explained: Why You Might Want to Invest
- Tempus AI: A Game-Changer in AI-Powered Healthcare
Receive News & Ratings for Levi Strauss & Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Levi Strauss & Co. and related companies with MarketBeat.com's FREE daily email newsletter.